Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial
P Calverley, R Pauwels, J Vestbo, P Jones, N Pride… - The Lancet, 2003 - thelancet.com
Background Inhaled longacting β 2 agonists improve lung function and health status in
symptomatic chronic obstructive pulmonary disease (COPD), whereas inhaled …
symptomatic chronic obstructive pulmonary disease (COPD), whereas inhaled …
Canadian Thoracic Society Clinical Practice Guideline on pharmacotherapy in patients with COPD–2019 update of evidence
In this guideline update, we highlight important and new findings related to pharmacological
therapy of chronic obstructive pulmonary disease (COPD) that should change clinical …
therapy of chronic obstructive pulmonary disease (COPD) that should change clinical …
[HTML][HTML] Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease
DP Tashkin, GT Ferguson - Respiratory research, 2013 - Springer
Chronic obstructive pulmonary disease (COPD) represents a significant cause of global
morbidity and mortality, with a substantial economic impact. Recent changes in the Global …
morbidity and mortality, with a substantial economic impact. Recent changes in the Global …
Long-term triple therapy de-escalation to indacaterol/glycopyrronium in patients with chronic obstructive pulmonary disease (SUNSET): a randomized, double-blind …
KR Chapman, JR Hurst, SM Frent, M Larbig… - American journal of …, 2018 - atsjournals.org
Rationale: There are no studies on withdrawal of inhaled corticosteroids in patients on long-
term triple therapy in the absence of frequent exacerbations. Objectives: To evaluate the …
term triple therapy in the absence of frequent exacerbations. Objectives: To evaluate the …
Contemporary management of chronic obstructive pulmonary disease: scientific review
Context The care of patients with chronic obstructive pulmonary disease (COPD) has
changed radically over the past 2 decades, and novel therapies can not only improve the …
changed radically over the past 2 decades, and novel therapies can not only improve the …
[HTML][HTML] Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis
Background Most patients with chronic obstructive pulmonary disease (COPD) receive
inhaled long-acting bronchodilators and inhaled corticosteroids. Conventional meta …
inhaled long-acting bronchodilators and inhaled corticosteroids. Conventional meta …